Advertisement

Journal of Endocrinological Investigation

, Volume 27, Issue 5, pp 496–509 | Cite as

Magnetic resonance imaging of the hypothalamuspituitary unit in children suspected of hypopituitarism: Who, how and when to investigate

  • M. Maghnie
  • S. Ghirardello
  • E. Genovese
Review Article

Abstract

The magnetic resonance (MR) identification of pituitary hyperintensity in the posterior part of the sella has been the most striking recent finding contributing to the diagnosis of “idiopathic” and permanent GH deficiency (GHD). Moreover, advancements in DNA technology have shed new light on the study of the genetic causes of hypopituitarism. Abnormalities in two genes, the GH-N encoding the GH and the GHRH receptor (GHRH-R), have been identified, while mutations in five other gene-encoding transcription factors such as Pit-1, Prop-1, Hesx-1, Lhx-3 and Lhx-4 involved in anterior pituitary development, have also been described. MR imaging shows marked differences in pituitary morphology indicating different GHD etiologies and different prognoses. Ectopic posterior pituitary is a specific marker of permanent GHD. These patients do not have Pit-1, Prop-1, or Lhx-3 mutations and should be carefully monitored for evolving pituitary hormone defects, though they do not require GH re-evaluation in adulthood; selected cases may have Hesx-1 or Lhx-4 mutations. MR evidence of normal or small anterior pituitary gland, enlarged empty sella, pituitary hyperplasia and/or intrasellar or suprasellar mass when associated with combined pituitary hormone deficiency call for molecular analysis of Pit-1, Prop-1, Hesx-1, or Lhx-3. Limitation of neck rotation and Chiari-I malformation may suggest Lhx-3 or Lhx-4 mutations (exceedingly rare). In “idiopathic” isolated GHD, evidence of normal anterior or small anterior pituitary size with normal location of posterior pituitary and normal connection between the hypothalamus and pituitary gland is suggestive of “transitory” or false positive GHD; patients with such characteristics should be re-evaluated well before reaching adult height. In selected cases, anterior pituitary height that is 2 SD below age-adjusted normal pituitary height could be suggestive of GHRH-R gene defect; it is worth pointing out that normal pituitary MR together with severe GHD has been observed, though rarely, in subjects with a genetic origin of GHD.

Key-words

Anterior pituitary GH deficiency Pit-1 Prop-1 Hesx-1 Lhx-3 Lhx-4 empty sella CPHD hypopituitarism MR posterior pituitary 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Caffey J. Pediatric X-ray diagnosis ed. 3. Chicago: Year Book Publishers, Inc. 1956, 115.Google Scholar
  2. 2.
    Di Chiro GD, Nelson KB. The volume of the sella turcica. Am J Roentgenol 1962, 87: 989–1008.Google Scholar
  3. 3.
    Lurie SN, Doraiswamy PM, Husain MM, et al. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 1990, 71: 505–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Suzuki M, Takashima T, Kadoya M, et al. Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr 1990, 14: 36–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R. Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 1991, 21: 247–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Tien RD, Kucharczyk J, Bessette J, Middleton M. MR imaging of the pituitary gland in infants and children: changes in size, shape and MR signal with growth and development. Am J Roentgenol 1992, 158: 1151–4.CrossRefGoogle Scholar
  7. 7.
    Triulzi F, Scotti G, di Natale B, et al. Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 1993, 93: 409–16.Google Scholar
  8. 8.
    Dietrich RB, Lis LE, Greensite FS, Pitt D. Normal MRI appearance of the pituitary gland in the first 2 years of life. Am J Neuroradiol 1995, 16: 1413–9.PubMedGoogle Scholar
  9. 9.
    Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climaterium. Am J Neuroradiol 1997, 18: 551–4.PubMedGoogle Scholar
  10. 10.
    Takano K, Utsunomiya H, Ono H, Ohfu M, Okazaki M. Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. Am J Neuroradiol 1999, 20: 312–5.PubMedGoogle Scholar
  11. 11.
    Elster A. Modern imaging of the pituitary. Radiology 1993, 187: 1–14.PubMedGoogle Scholar
  12. 12.
    Arrigo T, De Luca F, Maghnie M, et al. Relationship between neuroradiological and clinical features in apparently idiopathic hypopituitarism. Eur J Endocrinol 1998, 139: 84–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Abrahams JJ, Trefelner E, Boulware SD. Idiopathic growth hormone deficiency: MR findings in 35 patients. Am J Neuradiol 1991, 12: 155–60.Google Scholar
  14. 14.
    Cacciari E, Zucchini S, Carlà G, et al. Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance. Arch Dis Child 1990, 65: 1199–202.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Maghnie M, Triulzi F, Larizza D, et al. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J Clin Endocrinol Metab 1991, 73: 79–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Argyropoulou M, Perignon F, Brauner R, Brunelle F. Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J Pediatr 1992, 120: 886–91.PubMedCrossRefGoogle Scholar
  17. 17.
    Cacciari E, Zucchini S, Ambrosetto P, et al. Empty sella in children and adolescents with possible hypothalmic-pituitary disorders. J Clin Enocrinol Metab 1994, 78: 767–71.Google Scholar
  18. 18.
    Nagel BHP, Palmbach M, Petersen D, Ranke MB. Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. Eur J Pediatr 1997, 156: 758–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Chen S, Léger J, Garel C, Hassan M, Czernichow P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab 1999, 84: 2408–13.PubMedCrossRefGoogle Scholar
  20. 20.
    Tillmann V, Tang VWM, Price DA, Hughe DG, Wright NB, Clayton PE. Magnetic resonance imaging of the hypothalamic-pituitary axis in the diagnosis of growth hormone deficiency. J Pediatr Endocrinol Metab 2000, 13: 1577–83.PubMedGoogle Scholar
  21. 21.
    Osorio MGF, Marui S, Jorge AAL, et al. Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or Prop-1 genes. J Clin Endocrinol Metab 2002, 87: 5076–84.PubMedCrossRefGoogle Scholar
  22. 22.
    Arends NJT, Wv.d. Lip, SGF Robben, ACS Hokken-Koelega. MRI findings of the pituitary gland in short children born small for gestational age (SGA) in comparison with growth hormone-deficient (GHD) children and children with normal stature. Clinical Endocrinol (Oxf) 2002, 57: 719–24.CrossRefGoogle Scholar
  23. 23.
    Maghnie M, Triulzi F, Larizza D, et al. Hypothalamo-pituitary dwarfism: comparison between MR imaging and CT findings. Pediatr Radiol 1990, 20: 229–35.PubMedCrossRefGoogle Scholar
  24. 24.
    Vannelli S, Avataneo T, Benso L, et al. Magnetic resonance and the diagnosis of short stature of hypothalamic-hypophyseal origin. Acta Pediatr 1993, 82: 155–61.CrossRefGoogle Scholar
  25. 25.
    Zucchini S, di Natale B, Ambrosetto P, et al. Role of magnetic resonance imaging in hypothalamic-pituitary disorders. Horm Res 1995, 44 (suppl 3): 8–14.PubMedCrossRefGoogle Scholar
  26. 26.
    Pinto G, Netchine I, Sobrier ML, Brunelle F, Souberbielle JC, Brauner R. Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. J Clin Endocrinol Metab 1997, 82: 3450–4.PubMedGoogle Scholar
  27. 27.
    Maghnie M, Loche S, Cappa M. Pituitary magnetic resonance imaging in idiopathic and genetic growth hormone deficiency. J Clin Endocrinol Metab 2003, 88: 1911–2.PubMedCrossRefGoogle Scholar
  28. 28.
    Maghnie M, Genovese E, Villa A, Spagnolo L, Campani R, Severi F. Dynamic MRI in the congenital agenesis of the neural pituitary stalk syndrome: the role of the vascular pituitary stalk in predicting residual anterior pituitary function. Clinical Endocrinol (Oxf) 1996, 45: 281–90.CrossRefGoogle Scholar
  29. 29.
    Genovese E, Maghnie M, Beluffi G, et al. Hypothalamic-pituitary vascularization in the pituitary stalk transection sindrome: is the pituitary stalk really transected? The role of gadolinium-DTPA with spin echo T1 imaging and turbo-FLASH technique. Pediatr Radiol 1997, 27: 48–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Ultmann MC, Siegel SF, Hirsch WL, Finegold DN, Foley Jr TP. Pituitary stalk and ectopic hyperintense T1 signal on magnetic resonance imaging. Implications for anterior pituitary dysfunction. Am J Dis Child 1993, 147: 647–52.PubMedCrossRefGoogle Scholar
  31. 31.
    Kikuchi K, Fujisawa I, Momoi T, et al. Hypothalamic-pituitary function in growth hormone-deficient patients with pituitary stalk transection. J Clin Endocrinol Metab 1988, 67: 817–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Maghnie M, Larizza D, Triulzi F, Sanpaolo P, Scotti G, Severi F. Hypopituitarism and stalk agenesis: a congenital syndrome worsened by breech delivery?. Horm Res 1991, 35: 104–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Maghnie M, Larizza D, Zuliani I, Severi F. Congenital central nervous system abnormalities, idiopathic hypopituitarism and breech delivery: what is the connection?. Eur J Pediatr 1993, 152: 175–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Siegel SF, Ahdab-Barmada M, Arslanian S, Foley Jr TP. Ectopic posterior pituitary tissue and paracentric inversion of the short arm of chromosome 1 in twins. Eur J Endocrinol 1995, 133: 87–92.PubMedCrossRefGoogle Scholar
  35. 35.
    Larizza D, Maraschio P, Maghnie M, Sampaolo P. Hypogonadism in a patient with balanced X/18 translocation and pituitary hormone deficiency. Eur J Pediatr 1993, 152: 424–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Hamilton J, Chitayat D, Blaser S, Cohen LE, Phillips JA, Daneman D. Familial growth hormone deficiency associated with MRI abnormalities. Am J Med Genet 1998, 80: 128–32.PubMedCrossRefGoogle Scholar
  37. 37.
    Arifa N, Léger J, Garel C, Czernichow P, Hassan M. Cerebral anomalies associated with growth hormone insufficiency in children: major markers for diagnosis? Arch Pediatr 1999, 6: 14–21.PubMedCrossRefGoogle Scholar
  38. 38.
    Dupuis-Girod S, Gluckman E, Souberbielle JC, Brauner R. Growth hormone deficiency caused by pituitary stalk interruption in Fanconi’s anemia. J Pediatr 2001, 138: 129–33.PubMedCrossRefGoogle Scholar
  39. 39.
    Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998, 19: 125–33PubMedCrossRefGoogle Scholar
  40. 40.
    Machinis K, Pantel J, Netchine I, et al. Syndromic short stature in patients with a germline mutation in the LIM homeo-box. Am J Hum Genet 2001, 69: 961–8.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocrine Reviews 2002, 23: 431–42.PubMedCrossRefGoogle Scholar
  42. 42.
    Zucchini S, Ambrosetto P, Baroncini C, Cacciari E. Normal pituitary size in two patients with growth hormone gene deletion. J Pediatr Endocrinol Metab 1996, 9: 545–8.PubMedGoogle Scholar
  43. 43.
    Wajnrajch MP, Gertner JM, Harbison MD, Chua Jr SC, Leibel RL. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 1996, 12: 88–90.PubMedCrossRefGoogle Scholar
  44. 44.
    Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 1993, 364: 208–13.PubMedCrossRefGoogle Scholar
  45. 45.
    Wilson DB, Wyatt DP, Gadler RM, Baker CA. Quantitative aspects of growth hormone cell maturation in the normal and little mutant mouse. Acta Anat (Basel) 1988, 131: 150–5.CrossRefGoogle Scholar
  46. 46.
    Murray RA, Maheshwari HG, Russel EJ, Baumann G. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. Am J Neuroradiol 2000, 21: 685–9.PubMedGoogle Scholar
  47. 47.
    Oliveira HA, Salvatori R, Krauss MPO, Oliveira CR, Silva PR, Aguiar-Oliveira MH. Magnetic resonance imaging study of pituitari morphology in subjects homozygous for a null mutation of the growth hormone releasing hormone receptor gene. Euro J Endocrinol 2003, 148: 427–32.CrossRefGoogle Scholar
  48. 48.
    Frohman LA, Kineman RD. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol Metab 2002, 137: 299–303.CrossRefGoogle Scholar
  49. 49.
    Li S, Crenshaw III EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain Pit-1. Nature 1990, 347: 528–33.PubMedCrossRefGoogle Scholar
  50. 50.
    Radovick S, Nations M, Du Yuefen, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992, 257: 1115–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Ohta K, Nobukuni Y, Mitsubuchi H, et al. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun. 1992, 189: 851–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Okamoto N, Wada Y, Ida S, et al. Monoallelic expression of normal mRNA in the Pit-1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype. Hum Mol Genet 1994, 3: 1565–8.PubMedCrossRefGoogle Scholar
  53. 53.
    De Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995, 80: 3127–30.PubMedGoogle Scholar
  54. 54.
    Cohen LE, Wondisford FE, Salvatoni A, et al. A “Hot Spot” in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995, 80: 679–84.PubMedGoogle Scholar
  55. 55.
    Aarskog D, Eiken HG, Bjerknes R, Myking OL. Pituitary dwarfism in the R271W Pit-1 gene mutation. Eur J Pediatr 1997, 156: 829–34.PubMedCrossRefGoogle Scholar
  56. 56.
    Ward L, Chavez M, Huot C, et al. Severe congenital hypopituitarism with low prolactin levels and age-dependent anterior pituitary hypoplasia: a clue to a Pit-1 mutation. J Pediatr 1998, 132: 1036–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Arnhold IJP, Nery M, Brown MR, et al. Clinical and molecular characterization of a brazilian patient with Pit-1 deficiency. J Ped Endocrinol Metab 1998, 11: 623–30.CrossRefGoogle Scholar
  58. 58.
    Pfäffle RW, DiMattia GE, Parks JS, et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992, 257: 1118–21.PubMedCrossRefGoogle Scholar
  59. 59.
    Sornson MW, Wu W, Dasen JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996, 384: 327–33.PubMedCrossRefGoogle Scholar
  60. 60.
    Deladoëy J, Flück C, Büyükgebiz A, et al. “Hot spot” in the Prop-1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999, 84: 1645–50.PubMedGoogle Scholar
  61. 61.
    Wu W, Cogan JD, Pfäffle RW, et al. Mutations in Prop-1 cause familial combined pituitary hormone deficiency. Nat Genet 1998, 18: 147–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Flück C, Deladoey J, Rutishauser K, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a Prop-1 gene mutation resulting in the substitution of Arg(Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998, 83: 3727–34.PubMedGoogle Scholar
  63. 63.
    Arroyo A, Pernasetti F, Vasilyev VV, Amato P, Yen SSC, Mellon PL. A unique case of combined pituitary hormone deficiency caused by a Prop-1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf) 2002, 57: 283–91.CrossRefGoogle Scholar
  64. 64.
    Vieira TC, da Silva DMR, Cerutti JM, et al. Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of prophet of Pit-1 presenting as constitutional growth delay. J Clin Endocrinol Metab 2003, 88: 38–44.PubMedCrossRefGoogle Scholar
  65. 65.
    Mendonca BB, Osorio MGF, Latronico AC, et al. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the Prop-1 gene. J Clin Endocrinol Metab 1999, 84: 942–5.PubMedGoogle Scholar
  66. 66.
    Rosembloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the Prop-1 gene. J Clin Endocrinol Metab 1999, 84: 50–7.Google Scholar
  67. 67.
    Netchine I, Esteva B, Blustajn J, et al. Onset of hypocortisolism in a familial case of combined pituitary hormone deficiency caused by a mutation in the Prop-1 gene is independent of anterior pituitary size variation. Horm Res 2002, 58 (suppl 2): 96 (abstract).Google Scholar
  68. 68.
    Pernasetti F, Toledo SPA, Vasilyev VV, et al. Impaired adreno-corticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302 delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 2000, 85: 390–7.PubMedGoogle Scholar
  69. 69.
    Pfäffle R, Blankenstein O, Wüller S, Heimann K, Heimann G. Pituitary transcription factors, POU1F1 and Prop-1 defects. In: Rappaport R, Amselem S eds. Hypothalamic-pituitary development. Basel: Karger 2001, Vol. 4, p. 61–7.CrossRefGoogle Scholar
  70. 70.
    Fofanova O, Takamura N, Kinoshita EI, et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with Prop-1 mutations. Am J Roentgenol 2000, 174: 555–9.CrossRefGoogle Scholar
  71. 71.
    Parks JS, Tenore A, Bongiovanni AM, Kirkland RT. Familial hypopituitarism with large sella turcica. N Engl J Med 1978, 298: 698–702.PubMedCrossRefGoogle Scholar
  72. 72.
    Riepe FG, Partsch CJ, Blankenstein O, Mönig H, Pfäffle RW, Sippell WG. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to Prop-1 mutation. J Clin Endocrinol Metab 2001, 86: 4353–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Voutetakis A, Sertedaki A, Maniati-Christidi M, Dacou-Voutetakis C. Prop-1 mutations in multiple pituitary hormone deficiency (MPHD). Diverse phenotype and pituitary anatomy. Horm Res 2000, 53 (suppl): 58 (abstract).Google Scholar
  74. 74.
    Teinturier C, Vallette S, Adamsbaum C, Bendaoud M, Brue T, Bougnères PF. Pseutumor of the pituitary due to Prop-1 deletion. J Ped Endocrinol Metab 2002, 15: 95–101.CrossRefGoogle Scholar
  75. 75.
    Vallette-Kasic S, Barlier A, Teinturier C, et al. Prop-1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001, 86: 4529–35.PubMedCrossRefGoogle Scholar
  76. 76.
    Turton JPG, Mehta A, Woods KS, Cassar J, Hindmarsh PC, Dattani MT. Mutations within the transcription factor Prop-1 are associated with a pituitary mass that can rapidly involute. 85th Annual Meeting Endocrine Society 2003, June 19–22: 460 (abstract).Google Scholar
  77. 77.
    Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP. Heritable disorders of pituitary development. J Clin Endocrinol Metab 1999, 84: 4362–70.PubMedGoogle Scholar
  78. 78.
    Netchine I, Sobrier ML, Krude H, et al. Mutations in Lhx3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000, 25: 182–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Raetzman LT, Ward R, Camper SA. Lhx4 and Prop-1 are required for cell survival and expansion of the pituitary primordia. Development 2002, 129: 4229–39.PubMedGoogle Scholar
  80. 80.
    Dattani MT, Robinson IC. Hesx1 and Septo-Optic Dysplasia. Rev Endocrinol Metab Disord 2002, 3: 289–300.CrossRefGoogle Scholar
  81. 81.
    Brickman JM, Clements M, Tyrell R, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001, 128: 5189–99.PubMedGoogle Scholar
  82. 82.
    Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous Hesx1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 200, 10: 39–45.Google Scholar
  83. 83.
    Carvalho LR, Woods KS, Zamparini AL, et al. Evolving combined pituitary hormone deficiency (CPHD) and ectopic posterior pituitary (EPP) is associated with a novel homozygous missense mutation (I26T) in the Hesx1 repressor domain. Horm Res 2002, 58 (suppl): 95 (abstract).Google Scholar
  84. 84.
    Netchine I, Heinrichs C, Thibaud N, et al. Aplasia of the anterior pituitary and optic nerve coloboma due to a germline retrotransposition insertion event disrupting the homeodomain of Hesx1. Horm Res 2002, 58 (suppl): 95 (abstract).Google Scholar
  85. 85.
    Tajima T, Hattorri T, Nakajima T, et al. Sporadic heterozygous frameshift mutation of Hesx1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 2003, 88: 45–50.PubMedCrossRefGoogle Scholar
  86. 86.
    Sloop KW, Parker GE, Hanna KR, Wright HA, Rhodes SJ. Lhx3 transcription factor mutations associated with combined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 2001, 265: 61–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Sobrier ML, Netchine I, Attie T, Encha-Razavi F, Vekemans M, Amselem S. Lhx3 mutation involvement in syndromic combined pituitary hormone deficiency: molecular mechanism and Lhx3 expression pattern during early human development. 85th Annual Meeting Endocrine Society 2003, June 19–22: 112 (abstract).Google Scholar
  88. 88.
    Sheng HZ, Zhadanov AB, Mosinger Jr B, et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996, 272: 1004–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Palme C, Bellone F, Schonau E, et al. Frequency and phenotype of panhypopituitarism due to LHX-3 gene defects. Horm Res 2003, 60 (suppl): 1–137 (abstract).Google Scholar
  90. 90.
    Sloop KW, Walvoord EC, Showalter AD, Pescovitz OH, Rhodes SJ. Molecular analysis of Lhx3 and Prop-1 in pituitary hormone deficiency patients with posterior pituitary ectopia. J Clin Endocrinol Metab 2000, 85: 2701–8.PubMedGoogle Scholar
  91. 91.
    Maghnie M, Strigazzi C, Tinelli C, et al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adult. J Clin Endocrinol Metab 1999, 84: 1324–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Loche S, Bizzarri C, Maghnie M, et al. Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. J Pediatr 2002, 140: 445–9.PubMedCrossRefGoogle Scholar
  93. 93.
    Adan L, Souberbielle JC, Brauner R. Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab 1994, 78: 353–8.PubMedGoogle Scholar
  94. 94.
    Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM. Growth and adult height in GH-treated children with non-acquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab 2001, 86: 4649–54.PubMedCrossRefGoogle Scholar
  95. 95.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J. Presence of MRI abnormalities of the hypothalamic pituitary axis is a significant determinant of the first 3 year growth response to hGH treatment in prepubertal children with non-acquired growth hormone deficiency. Clin Endocrinol (Oxf) (In Press).Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2004

Authors and Affiliations

  • M. Maghnie
    • 1
  • S. Ghirardello
    • 1
  • E. Genovese
    • 2
  1. 1.Department of Pediatrics, IRCCS S. Matteo PoliclinicUniversity of PaviaPaviaItaly
  2. 2.Department of RadiologyUniversity of InsubriaVareseItaly

Personalised recommendations